• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰 S1PR1 或 STAT3 的表达可减轻风湿性心脏病引起的瓣膜损伤。

Interference with the expression of S1PR1 or STAT3 attenuates valvular damage due to rheumatic heart disease.

机构信息

Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.

出版信息

Int J Mol Med. 2021 Sep;48(3). doi: 10.3892/ijmm.2021.5012. Epub 2021 Jul 23.

DOI:10.3892/ijmm.2021.5012
PMID:34296288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8354313/
Abstract

Rheumatic heart disease (RHD) affects numerous individuals annually; however, its pathogenesis remains unclear. The sphingosine 1‑phosphate receptor 1 (S1PR1) and signal transducer and activator of transcription 3 (STAT3) have recently been shown to be involved in valvular damage via the promotion of the differentiation of T helper 17 (Th17) cells during the development of RHD‑induced valvular damage. The present study investigated whether altering the expression of S1PR1 or STAT3 attenuates valvular damage due to RHD. Inactivated group A streptococcus (GAS) was used to establish a rat model of RHD. Recombinant adeno‑associated viral vectors carrying an S1PR1 overexpression sequence were used to overexpress S1PR1. STAT3 small interfering RNA (STAT3‑siRNA) was used to inhibit STAT3 expression. Reverse transcription‑quantitative PCR (RT‑qPCR) was performed to detect the mRNA expression of S1PR1, STAT3, collagen type III α1 chain (Col3a1) and fibroblast‑specific protein 1. Western blotting (WB) and immunohistochemistry were used to detect the levels of S1PR1, STAT3, phosphorylated (p‑) STAT3, and retinoic acid‑related orphan receptor γT (RORγt) proteins. Enzyme‑linked immunosorbent assays (ELISAs) and immunohistochemistry were used to detect the levels of interleukin (IL)‑6 and IL‑17. Hematoxylin and eosin (H&E) staining and Sirius Red staining were performed to evaluate the degree of inflammation and fibrosis in the valvular tissues. S1PR1 expression was decreased in the valvular tissues of the rats with RHD. The levels of IL‑6, IL‑17 and p‑STAT3 in the rats with RHD were increased. The degree of valvular inflammation and fibrosis in the rats with RHD was also increased. The overexpression of S1PR1 and the inhibition of STAT3 reduced the total p‑STAT3 level, resulting in decreased levels of IL‑6, IL‑17 and RORγt, and a reduced degree of valvular inflammation and fibrosis. These results suggest that the expression of S1PR1 and STAT3 may be involved in valvular tissue damage due to RHD. Thus, strategies designed to interfere with the expression of S1PR1 or STAT3 may affect the expression of Th17 cell‑related cytokines and may thus attenuate valvular damage due to RHD.

摘要

风湿性心脏病(Rheumatic heart disease,RHD)每年都会影响大量人群,但发病机制尚不清楚。最近的研究表明,在 RHD 诱导的瓣膜损伤发展过程中,通过促进辅助性 T 细胞 17(Th17)细胞的分化,鞘氨醇 1-磷酸受体 1(S1PR1)和信号转导和转录激活因子 3(STAT3)参与了瓣膜损伤。本研究旨在探讨改变 S1PR1 或 STAT3 的表达是否可以减轻 RHD 引起的瓣膜损伤。采用失活 A 组链球菌(group A streptococcus,GAS)建立 RHD 大鼠模型。采用携带 S1PR1 过表达序列的重组腺相关病毒载体过表达 S1PR1。采用 STAT3 小干扰 RNA(STAT3-small interfering RNA,STAT3-siRNA)抑制 STAT3 表达。采用反转录-定量聚合酶链反应(reverse transcription-quantitative PCR,RT-qPCR)检测 S1PR1、STAT3、Ⅲ型胶原α1 链(collagen type Ⅲα1 chain,Col3a1)和成纤维细胞特异性蛋白 1(fibroblast-specific protein 1,FSP1)的 mRNA 表达。采用蛋白质印迹法(Western blot,WB)和免疫组织化学染色检测 S1PR1、STAT3、磷酸化 STAT3(p-STAT3)和维甲酸相关孤儿受体γT(retinoic acid-related orphan receptor γT,RORγt)蛋白的水平。采用酶联免疫吸附试验(enzyme-linked immunosorbent assay,ELISA)和免疫组织化学染色检测白细胞介素(interleukin,IL)-6 和 IL-17 的水平。采用苏木精和伊红(hematoxylin and eosin,H&E)染色和天狼猩红染色评估瓣膜组织的炎症和纤维化程度。结果显示,RHD 大鼠瓣膜组织中 S1PR1 表达降低。RHD 大鼠 IL-6、IL-17 和 p-STAT3 水平升高。RHD 大鼠瓣膜炎症和纤维化程度也增加。S1PR1 过表达和 STAT3 抑制降低了总 p-STAT3 水平,导致 IL-6、IL-17 和 RORγt 水平降低,瓣膜炎症和纤维化程度减轻。这些结果表明,S1PR1 和 STAT3 的表达可能参与了 RHD 引起的瓣膜组织损伤。因此,设计干扰 S1PR1 或 STAT3 表达的策略可能会影响 Th17 细胞相关细胞因子的表达,从而减轻 RHD 引起的瓣膜损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe2/8354313/587be4032d91/IJMM-48-03-05012-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe2/8354313/b73d689c961a/IJMM-48-03-05012-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe2/8354313/797491e6d419/IJMM-48-03-05012-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe2/8354313/9d7c72444351/IJMM-48-03-05012-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe2/8354313/6e52c3d86bd6/IJMM-48-03-05012-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe2/8354313/587be4032d91/IJMM-48-03-05012-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe2/8354313/b73d689c961a/IJMM-48-03-05012-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe2/8354313/797491e6d419/IJMM-48-03-05012-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe2/8354313/9d7c72444351/IJMM-48-03-05012-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe2/8354313/6e52c3d86bd6/IJMM-48-03-05012-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fe2/8354313/587be4032d91/IJMM-48-03-05012-g04.jpg

相似文献

1
Interference with the expression of S1PR1 or STAT3 attenuates valvular damage due to rheumatic heart disease.干扰 S1PR1 或 STAT3 的表达可减轻风湿性心脏病引起的瓣膜损伤。
Int J Mol Med. 2021 Sep;48(3). doi: 10.3892/ijmm.2021.5012. Epub 2021 Jul 23.
2
Inhibition of miR‑155‑5p attenuates the valvular damage induced by rheumatic heart disease.miR-155-5p 的抑制可减轻风湿性心脏病引起的瓣膜损伤。
Int J Mol Med. 2020 Feb;45(2):429-440. doi: 10.3892/ijmm.2019.4420. Epub 2019 Dec 6.
3
Potential involvement of S1PR1/STAT3 signaling pathway in cardiac valve damage due to rheumatic heart disease.S1PR1/STAT3信号通路在风湿性心脏病所致心脏瓣膜损伤中的潜在作用。
Biotech Histochem. 2019 Aug;94(6):398-403. doi: 10.1080/10520295.2019.1574028. Epub 2019 Feb 4.
4
Activation of activin/Smad2 and 3 signaling pathway and the potential involvement of endothelial‑mesenchymal transition in the valvular damage due to rheumatic heart disease.激活素/Smad2 和 3 信号通路及内皮-间质转化在风湿性心脏病瓣膜损伤中的潜在作用。
Mol Med Rep. 2021 Jan;23(1). doi: 10.3892/mmr.2020.11648. Epub 2020 Nov 12.
5
CD4 T cells and TGFβ1/MAPK signal pathway involved in the valvular hyperblastosis and fibrosis in patients with rheumatic heart disease.CD4 T 细胞及 TGFβ1/MAPK 信号通路与风湿性心脏病患者瓣膜组织的过度增生和纤维化相关。
Exp Mol Pathol. 2020 Jun;114:104402. doi: 10.1016/j.yexmp.2020.104402. Epub 2020 Feb 13.
6
The Role of Interleukin-13 in Patients with Rheumatic Valvular Fibrosis: A Clinical and Histological Study.白细胞介素-13在风湿性瓣膜纤维化患者中的作用:一项临床与组织学研究。
J Heart Valve Dis. 2015 Jul;24(4):496-501.
7
LINC00707 inhibits myocardial fibrosis and immune disorder in rheumatic heart disease by regulating miR-145-5p/S1PR1.LINC00707 通过调控 miR-145-5p/S1PR1 抑制风湿性心脏病心肌纤维化及免疫紊乱。
Biotechnol Genet Eng Rev. 2024 Dec;40(4):3073-3086. doi: 10.1080/02648725.2023.2204598. Epub 2023 Apr 21.
8
Inhibition of Macrophage Recruitment to Heart Valves Mediated by the C-C Chemokine Receptor Type 2 Attenuates Valvular Inflammation Induced by Group A Streptococcus in Lewis Rats.C-C 趋化因子受体 2 抑制巨噬细胞募集到心脏瓣膜可减轻 A 组链球菌引起的路易斯大鼠心脏瓣膜炎症。
Front Biosci (Landmark Ed). 2024 Aug 22;29(8):303. doi: 10.31083/j.fbl2908303.
9
Potential Involvement of M1 Macrophage and VLA4/VCAM-1 Pathway in the Valvular Damage Due to Rheumatic Heart Disease.M1巨噬细胞和VLA4/VCAM-1通路在风湿性心脏病所致瓣膜损害中的潜在作用
Front Biosci (Landmark Ed). 2024 Jun 18;29(6):219. doi: 10.31083/j.fbl2906219.
10
S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.S1PR1 通过激活 STAT3 通路促进食管鳞癌细胞的增殖和抑制凋亡。
J Exp Clin Cancer Res. 2019 Aug 22;38(1):369. doi: 10.1186/s13046-019-1369-7.

引用本文的文献

1
Expression profiles and bioinformatic analysis of circular RNA in rheumatic heart disease: potential hsa_circ_0001490 and hsa_circ_0001296 as a diagnostic biomarker.风湿性心脏病中环状RNA的表达谱及生物信息学分析:潜在的诊断生物标志物hsa_circ_0001490和hsa_circ_0001296
Front Cardiovasc Med. 2025 Aug 1;12:1639767. doi: 10.3389/fcvm.2025.1639767. eCollection 2025.
2
Analysis of the Correlation Between the Expression of T-Helper Type 17 Cell-Related Cytokines and Valve Damage in Rheumatic Heart Disease.17型辅助性T细胞相关细胞因子表达与风湿性心脏病瓣膜损害的相关性分析
Cureus. 2024 Oct 31;16(10):e72759. doi: 10.7759/cureus.72759. eCollection 2024 Oct.
3

本文引用的文献

1
Integrin α5 promotes migration and invasion through the FAK/STAT3/AKT signaling pathway in icotinib-resistant non-small cell lung cancer cells.整合素α5通过FAK/STAT3/AKT信号通路促进对埃克替尼耐药的非小细胞肺癌细胞的迁移和侵袭。
Oncol Lett. 2021 Jul;22(1):556. doi: 10.3892/ol.2021.12817. Epub 2021 May 24.
2
Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway.二氢丹参酮通过抑制JAK2/STAT3信号通路抑制肝细胞癌
Front Pharmacol. 2021 Apr 29;12:654986. doi: 10.3389/fphar.2021.654986. eCollection 2021.
3
IL-9-triggered lncRNA Gm13568 regulates Notch1 in astrocytes through interaction with CBP/P300: contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
Methods for Establishing a Rat Model of Rheumatic Heart Disease.
建立风湿性心脏病大鼠模型的方法。
Rev Cardiovasc Med. 2024 Sep 24;25(9):346. doi: 10.31083/j.rcm2509346. eCollection 2024 Sep.
4
JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target.心脏纤维化中的JAK/STAT3信号传导:一个有前景的治疗靶点。
Front Pharmacol. 2024 Mar 1;15:1336102. doi: 10.3389/fphar.2024.1336102. eCollection 2024.
IL-9 触发的长非编码 RNA Gm13568 通过与 CBP/P300 的相互作用调节星形胶质细胞中的 Notch1:有助于实验性自身免疫性脑脊髓炎的发病机制。
J Neuroinflammation. 2021 May 11;18(1):108. doi: 10.1186/s12974-021-02156-5.
4
PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation.PKM2 通过精细调节 STAT3 激活促进 Th17 细胞分化和自身免疫炎症。
J Exp Med. 2020 Oct 5;217(10). doi: 10.1084/jem.20190613.
5
Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology.鞘氨醇-1-磷酸在心血管生理学和病理学中的意义。
Pharmacol Res. 2020 Jun;156:104793. doi: 10.1016/j.phrs.2020.104793. Epub 2020 Apr 8.
6
CD4 T cells and TGFβ1/MAPK signal pathway involved in the valvular hyperblastosis and fibrosis in patients with rheumatic heart disease.CD4 T 细胞及 TGFβ1/MAPK 信号通路与风湿性心脏病患者瓣膜组织的过度增生和纤维化相关。
Exp Mol Pathol. 2020 Jun;114:104402. doi: 10.1016/j.yexmp.2020.104402. Epub 2020 Feb 13.
7
Endothelial sphingosine 1-phosphate receptors promote vascular normalization and antitumor therapy.内皮鞘氨醇 1-磷酸受体促进血管正常化和抗肿瘤治疗。
Proc Natl Acad Sci U S A. 2020 Feb 11;117(6):3157-3166. doi: 10.1073/pnas.1906246117. Epub 2020 Jan 27.
8
Differential Expression of Genes and on Circulating CD4+ T Cells in Multiple Sclerosis and Crohn's Disease.多发性硬化症和克罗恩病患者循环 CD4+T 细胞中基因和的差异表达。
Int J Mol Sci. 2020 Jan 20;21(2):676. doi: 10.3390/ijms21020676.
9
Inhibition of miR‑155‑5p attenuates the valvular damage induced by rheumatic heart disease.miR-155-5p 的抑制可减轻风湿性心脏病引起的瓣膜损伤。
Int J Mol Med. 2020 Feb;45(2):429-440. doi: 10.3892/ijmm.2019.4420. Epub 2019 Dec 6.
10
Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway.内皮 S1pr1 通过 AKT-eNOS 通路调节压力超负荷诱导的心肌重构。
J Cell Mol Med. 2020 Jan;24(2):2013-2026. doi: 10.1111/jcmm.14900. Epub 2019 Dec 19.